InnoPharmax
About
About Us
Organization
Our History
News
News
Technologies
OralPAS®
OralPAS Pro®
MUCR™
R&D
Pipeline
D07001 GemOral
D0191801 Oral Insulin
D0282102 Bendamustine RTD
Products
Oncology Agents
Drugs for Rare Diseases
Anti-infection Agents
Contrast Agents
Immunological Agents
Active Pharmaceutical Ingredient
Investors
Financial Information
Company Profile
Monthly Revenue
Financial Statements
Corporate Governance
Board Meeting
Committee
Internal Audit
Rule of Procedure
Corporate Social Responsibility
Shareholders Services
Annual Reports
Shareholders' Meetings
Announcements
Contact
Contacts
Contact Information
Career Opportunities
中
News
News
News
>
News
>
home
D07001 (GemOral) Phase II/III clinical trial in humans for advanced bile duct cancer (Project No. INNO-GO-05) has been approved
D07001 (GemOral) Phase II/III clinical trial in humans for advanced bile duct cancer (Project No. INNO-GO-05) has been approved by Taiwan Food and Drug Administration (TFDA).
Back
uGear Design
-
Website Info.
